| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |